Buy or sell Ancora Heart stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Ancora Heart Stock
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
About Ancora Heart Stock
Ancora Heart is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an investigational therapy designed to repair the enlarged left ventricle targeting the underlying cause of heart failure. The AccuCinch heart failure treatment was created to benefit the millions of patients who otherwise have no minimally invasive option available to them.
Funding History
April 2010 | $30.0M |
---|---|
May 2018 | $17.8M |
December 2018 | $23.5M |
July 2021 | $80.0M |
Management
Board Observer
Naveen Yalamanchi
President and CEO
Jeffrey M. Closs
Vice President, Clinical Marketing
Bart Beasley
CTO
Russel Sampson
Vice President, Regulatory Affairs and Quality Assurance
Mike Fritz
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase